Filing Details
- Accession Number:
- 0000920465-18-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-20 21:06:18
- Reporting Period:
- 2018-08-16
- Accepted Time:
- 2018-08-20 21:06:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920465 | La Jolla Pharmaceutical Co | LJPC | Biological Products, (No Disgnostic Substances) (2836) | 330361285 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1693858 | James Rolke | C/O La Jolla Pharmaceutical Company, 4550 Towne Centre Court San Diego CA 92121 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-16 | 1,000 | $22.00 | 74,328 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
